Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

6.30
Delayed Data
As of Mar 04
 -0.02 / -0.32%
Today’s Change
5.06
Today|||52-Week Range
13.18
-10.00%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close6.32
Today’s open6.33
Day’s range6.12 - 6.37
Volume145,737
Average volume (3 months)676,889
Market cap$99.2M
Dividend yield--
Data as of 3:59pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+33.68%
Earnings growth (this year)-153.33%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
TNXPTonix Pharmaceutical...+0.34+5.62%
BLRXBioLine RX Ltd+0.25+9.65%
CTRVContraVir Pharmaceut...+0.36+8.29%
COCPCocrystal Pharma Inc+0.11+13.76%
Data as of 3:59pm ET, 03/04/2015

Financials

Next reporting dateMarch 26, 2015
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$4.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account